A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil

Transplantation

Volumn 71, Issue 4, 2001, Pages 508-515

  Ringe, Burckhardt ^a,b,c,d,e   Braun, Felix ^a,b,c,d,e   Schütz, Ekkehard ^a,b,c,d,e   Füzesi, Lazlo ^a,b,c,d,e   Lorf, Thomas ^a,b,c,d,e   Canelo, Ruben ^a,b,c,d,e   Oellerich, Michael ^a,b,c,d,e   Ramadori, Guiliano ^a,b,c,d,e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Klinik fur Transplantationschirurgie   (Germany)

^c Abteilung Klinische Chemie   (Germany)

^d Abteilung Gastroenteropathologie   (Germany)

^e Abteilung Gastroenterologie und Endokrinologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ENZYME IMMUNOASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TREATMENT OUTCOME;

EID: 0035956881     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200102270-00005     Document Type: Article

References (39)

1. Effect of cortisone on survival of skin homografts in rabbits
2. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance
3. Clucocorticosteroids and organ transplantation
4. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy
5. Stratgies to reduce or replace steroid dosing
6. Prolonged survival of liver transplants in the pig
7. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system
8. Immunopathogenesis of hepatitis B and hepatitis C infection in the nonimmunosuppressed and immunosuppressed state
9. Management of viral hepatitis after liver transplantation
10. Immunsuppressive drugs
11. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: Experience with a steroid-sparing concept
12. Liver transplantation
13. Banff schema for grading liver allograft rejection: An international consensus document
14. Weaning of immunosuppression in liver transplant recipients
15. Ten years of liver transplantation
16. Immunosuppressive strategies in transplantation
17. Randomised trialomania? The multicentre liver transplant trials of tacrolimus
18. Immunosuppression in liver transplantation: A European Survey
19. Changing perspectives on the role of corticosteroids after liver transplantation
20. Incidence, timing, and risk factors for acute and chronic rejection
21. Early steroid withdrawal in liver transplantation is safe and beneficial
22. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation
23. A pilot study of immunosuppressive monotherapy in liver transplantation: Tacrolimus versus microemulsified cyclosporin
24. Sirolimus: A potent new immunosuppressant for liver transplantation
25. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation
26. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients
27. Mycophenolate mofetil as induction therapy after liver transplantation
28. Influence of tacrolimus on mycophenolate mofetil metabolism in an ex vivo isolated small bowel perfusion model
29. Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation
30. The molecular basis of cyclosporin A metabolism, pharmocokinetics and drug interactions
31. Therapeutic drug monitoring of cyclosporine and tacrolimus
32. Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric renal transplant recipients: Implications for therapeutic drug monitoring
33. Pharmacokinetics of mycophenolate mofetil (RS61443): A short review
34. How to handle mycophenolate mofetil in combination with tacrolimus?
35. Tacrolimus and mycophenolate mofetil regimens in transplantation
36. Pharmacokinetic-pharmacodynamic relationship for mycophenolic acid in renal transplant patients
37. Outcome of autoimmune hepatitis after liver transplantation
38. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis
39. Glucocorticoids inhibit progression of cell cycle pathways following ischemia/reperfusion (I/R) injury in the liver